. . . "Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in \"real-world\" clinical practice. A propensity-matched analysis of 76,940 patients"@en . . . "6" . . "wetenschappelijk artikel"@nl . . . . . . "scientific article published on 16 March 2017"@en . . . . "Xiaoyan Shawn Li" . . . . "28300870" . . "Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in \"real-world\" clinical practice. A propensity-matched analysis of 76,940 patients"@en . . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0432 \u0431\u0435\u0440\u0435\u0437\u043D\u0456 2017"@uk . "6291856" . . . . . . . . "Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in \"real-world\" clinical practice. A propensity-matched analysis of 76,940 patients"@nl . "Melissa Hamilton" . . "Ruslan Horblyuk" . . . . . . . "Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in \"real-world\" clinical practice. A propensity-matched analysis of 76,940 patients"@nl . . . "Xuemei Luo" . . . . "10.1160/TH17-01-0068" . "Allison Keshishian" . . . "article scientifique publi\u00E9 en 2017"@fr . "Kiran Gupta" . "Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in \"real-world\" clinical practice. A propensity-matched analysis of 76,940 patients"@en . . . . . . . "im M\u00E4rz 2017 ver\u00F6ffentlichter wissenschaftlicher Artikel"@de . . . . . . . . . . "Keith Friend" . . . . . "117" . . . . . . "2017-03-16T00:00:00Z"^^ . . "art\u00EDculu cient\u00EDficu espubliz\u00E1u en marzu de 2017"@ast . . . . . . . "Steve Deitelzweig" . . "1072-1082" . . . . . "Xianying Pan" . . . "Anagha Nadkarni" . . . . . "Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in \"real-world\" clinical practice. A propensity-matched analysis of 76,940 patients"@nl . . . . . . . . . . . . . . . "Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in \"real-world\" clinical practice. A propensity-matched analysis of 76,940 patients"@en . .